Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000. American College of Cardiology
J Am Coll Cardiol
.
2000 Jul;36(1):310-25.
doi: 10.1016/s0735-1097(00)00805-6.
Authors
N S Kleiman
1
,
R M Califf
Affiliation
1
Baylor College of Medicine, The Methodist Hospital, Section of Cardiology, Houston, Texas 77030, USA.
PMID:
10898457
DOI:
10.1016/s0735-1097(00)00805-6
No abstract available
Publication types
Review
MeSH terms
Angina Pectoris / therapy*
Angioplasty, Balloon, Coronary*
Fibrinolytic Agents / therapeutic use*
Humans
Randomized Controlled Trials as Topic*
Safety
Thrombolytic Therapy*
Treatment Outcome
United States
Substances
Fibrinolytic Agents